Peter Hobart

6.0k citations

54 papers · 4.8k indexed · 1 hit paper · h-index 31

Impact in

Virology top 1%
- HIV Research and Treatment
Immunology top 2%
- Immunotherapy and Immune Responses

Papers in

Virology 10
- HIV Research and Treatment 10
Molecular Biology 36
- RNA Interference and Gene Delivery 10
- vaccines and immunoinformatics approaches 10
- DNA and Nucleic Acid Chemistry 4

Co-authors: Richard C. Hedstrom Stephen L. Hoffman Martha Sedegah S L Hoffman Jon Norman Denise L. Doolan Yupin Charoenvit M Margalith
Journals: Human Gene Therapy (7 papers)Proceedings of the National Academy of Sciences (6 papers)Nature (4 papers)Vaccine (3 papers)Science (2 papers)
Partner nations: United States United Kingdom Austria

In The Last Decade

Peter Hobart

53 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine 1998 · 647 citations

Peers

Countries citing papers authored by Peter Hobart

Since Specialization

Citations

This map shows the geographic impact of Peter Hobart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hobart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hobart more than expected).

Fields of papers citing papers by Peter Hobart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hobart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hobart. The network helps show where Peter Hobart may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Hobart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Hobart Line = papers co-authored together Peter Hobart links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Association of aortic valve size with the degree of aortic valve calcification in severe high-gradient aortic stenosis European Heart Journal - Cardiovascular Imaging ·Baroness Jay, Gudrun Lamm, 浩招牧野, Andreas A. Kammerlander, Linda Romola, V Pergram, Peter Hobart, 博之関根, Méndez Bustillos J, Konstantin Schwarz, P Vock, Uta C. Hoppe, Julia Mascherbauer	2025	1
2	Plasmid Vaccines and Therapeutics: From Design to Applications Advances in biochemical engineering, biotechnology ·Marston Manthorpe, Peter Hobart, Gary Hermanson, Marilyn E. Ferrari, Andrew J. Geall, Ralf Kruppa, Alain Rolland	2005	16
3	Rabbit EPO Gene and cDNA: Expression of Rabbit EPO after Intramuscular Injection of pDNA Biochemical and Biophysical Research Communications ·Adrián Vilalta, Di Wu, M Margalith, Peter Hobart	2001	5
4	Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus The Journal of Immunology ·Martha Sedegah, Walter R. Weiss, John B. Sacci, Yupin Charoenvit, Richard C. Hedstrom, Kalpana Gowda, Victoria Majam, John A. Tine, Sanjai Kumar, Peter Hobart, Stephen L. Hoffman	2000	106
5	Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers Vaccine ·Thong P. Le, Kevin Coonan, Richard C. Hedstrom, Yupin Charoenvit, Martha Sedegah, Judith E. Epstein, Sanjai Kumar, Ruobing Wang, Denise L. Doolan, Jason D. Maguire, Suezanne E. Parker, Peter Hobart, Jon Norman, Stephen L. Hoffman	2000	174
6	The Prison Litigation Reform Act: Striking the Balance between Law and Order Villanova law review ·Peter Hobart	1999	1
7	Plasmid DNA Malaria Vaccine: Tissue Distribution and Safety Studies in Mice and Rabbits Human Gene Therapy ·Suezanne E. Parker, Flavia Borellini, Martin L. Wenk, Peter Hobart, Stephen L. Hoffman, Richard C. Hedstrom, Shane D Stoeber, Jon Norman	1999	82
8	Gene Chemistry: Functionally and Conformationally Intact Fluorescent Plasmid DNA Human Gene Therapy ·Olivier Zelphati, Xiaowu Liang, Peter Hobart, Philip L. Felgner	1999	106
9	Enhancer and Promoter Chimeras in Plasmids Designed for Intramuscular Injection: A Comparative In Vivo and In Vitro Study Human Gene Therapy ·Kerry M. Barnhart, Jukka Hartikka, Marston Manthorpe, Jon Norman, Peter Hobart	1998	20
10	1Organizers: Elizabeth G. Nabel and Inder Verma.2Organizers: Philip L. Felgner, Frank Szoka, Leaf Huang and Ernst Wagner.Keystone Symposia on: Molecular and Cellular Biology of Gene Therapy1 and Synthetic Non-Viral Gene Delivery Systems2 Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Gary J. Nabel, Peter Hobart	1998	1
11	DNA Vaccination as an Approach to Malaria Control: Current Status and Strategies Current topics in microbiology and immunology ·Denise L. Doolan, Richard C. Hedstrom, Malcolm J. Gardner, Martha Sedegah, Flemming Kirchler, Robert Gramzinski, M Margalith, Peter Hobart, Stephen L. Hoffman	1998	29
12	Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. The Journal of Experimental Medicine ·Denise L. Doolan, Martha Sedegah, Richard C. Hedstrom, Peter Hobart, Yupin Charoenvit, S L Hoffman	1996	222
13	DNA Vaccines against Malaria: Immunogenicity and Protection in a Rodent Model Journal of Pharmaceutical Sciences ·Malcolm J. Gardner, Denise L. Doolan, Richard C. Hedstrom, Ruobing Wang, Martha Sedegah, Robert Gramzinski, João C. Aguiar, Helen H. Wang, M Margalith, Peter Hobart, Stephen L. Hoffman	1996	28
14	An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle Human Gene Therapy ·Jukka Hartikka, Michael Sawdey, Ko-Hi Chang, M Margalith, Kerry M. Barnhart, かおり近藤, H. Lee Vahlsing, Jennifer Meek, Magda Marquet, Peter Hobart, Jon Norman, Marston Manthorpe	1996	280
15	Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. PubMed ·X Liang, Jukka Hartikka, Loretta Sukhu, Marston Manthorpe, Peter Hobart	1996	37
16	Nucleic Acid Malaria Vaccines Annals of the New York Academy of Sciences ·Stephen L. Hoffman, Denise L. Doolan, Martha Sedegah, Robert Gramzinski, R Wolf-Roberts, Kalpana Gowda, Peter Hobart, M Margalith, Zofia Anna Nawrocka, Richard C. Hedstrom	1995	28
17	X-ray analyses of peptide–inhibitor complexes define the structural basis of specificity for human and mouse renins Nature ·V. Dhanaraj, Chris Dealwis, Carlos Frazão, M. Badasso, B. L. Sibanda, Ian J. Tickle, J.B. Cooper, H.P.C. Driessen, Matthew Newman, C. F. Aguilar, S. P. Wood, Tom L. Blundell, Peter Hobart, Kieran F. Geoghegan, Mark Ammirati, Dennis E. Danley, Diana Barrow, Dennis J. Hoover	1992	102
18	Simple Procedure for Recovery of Crystallizable Human Recombinant Renin from Mammalian Cell-Conditioned Medium Advances in experimental medicine and biology ·Kieran F. Geoghegan, Anthony J. Lanzetti, Mark Ammirati, Dennis E. Danley, Diana Barrow, Peter Hobart	1991	1
19	The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDS Trends in Biochemical Sciences ·Tom L. Blundell, Risto Lapatto, Andrew F. Wilderspin, Andrew M. Hemmings, Peter Hobart, Dennis E. Danley, Peter J. Whittle	1990	62
20	X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes Nature ·Risto Lapatto, T. Blundell, Andrew M. Hemmings, John P. Overington, Andrew F. Wilderspin, Stephen Wood, James Merson, Peter J. Whittle, Dennis E. Danley, Kieran F. Geoghegan, Steven J. Hawrylik, A. Peter, 程金梅, Peter Hobart	1989	361

About Peter Hobart

Peter Hobart is a scholar working on Virology, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology and Biotechnology, having authored 54 papers that have together received 4.8k indexed citations. Recurring topics across this work include Malaria Research and Control (14 papers), RNA Interference and Gene Delivery (10 papers), vaccines and immunoinformatics approaches (10 papers), HIV Research and Treatment (10 papers), Mosquito-borne diseases and control (8 papers), Virus-based gene therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Virology (753 citations), Immunology (1.5k citations), Infectious Diseases (951 citations), Molecular Biology (2.6k citations) and Biotechnology (292 citations). Peter Hobart has collaborated with scholars based in United States, United Kingdom and Austria. Frequent co-authors include Richard C. Hedstrom, Stephen L. Hoffman, Martha Sedegah, S L Hoffman, Jon Norman, Denise L. Doolan, Yupin Charoenvit, M Margalith, M Sedegah and Trevor R. Jones. Their work appears in journals such as Human Gene Therapy, Proceedings of the National Academy of Sciences, Nature, Vaccine and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact